Journal article · 2023 · Open access
VEGFR-3 Stimulation on LECs Boosts Type 2 Immunity After Vaccination
The Journal of Immunology, 210(Supplement_1), 79.18 · Published 1 May 2023 · DOI 10.4049/jimmunol.210.supp.79.18
In brief
“VEGFR-3 Stimulation on LECs Boosts Type 2 Immunity After Vaccination” is a 2023 journal article by Trevin Robert Kurtanich and 2 co-authors, published in The Journal of Immunology. OpenAlex counts 0 citations as of 18 November 2026. It is open access: the full text is free to read at The Journal of Immunology.
- Citations
- 0
- Authors
- 3
Abstract
Lymphatic vessels are the main transport routes for fluid, antigens, exosomes, and immune cells from peripheral tissues to the lymph nodes (LNs). In addition to being pervasive through tissue, lymphatic vessels are also abundant within the LN, where they route lymph and cells around the B cell follicles and throughout the paracortical zone; thus, lymphatic endothelial cells (LECs) have unique access to lymph-borne molecules and interactions with immune cells. Upon acute inflammation or vaccination, LN LECs undergo expansion along with lymphocyte proliferation, a process dependent on the VEGF-C/VEGFR-3 signaling axis; however, it is not well understood how LN lymphatics and their expansion contribute to acute adaptive immune responses. Here, we asked how altering VEGFR-3 signaling LN LECs alters the adaptive immune response, using OVA + CpG (a TLR9 agonist) as a model for vaccination. We found that delivering VEGF-C156S, a VEGFR-3 specific agonist, multiple times prior to and concurrent with the inflammatory stimulus led to increased Th2 responses in terms of higher plasma levels of OVA-specific IgG1, more IgG1+ germinal center B cells, and increased production of Th2 cytokines (IL-4, IL-5, and IL-13) by CD4+ T cells upon restimulation. In loss-of-function experiments using a tamoxifen-inducible LEC-specific deletion of VEGFR-3, vaccination led to reduced plasma levels of OVA-specific IgG1 compared to tamoxifen-treated control littermates. Together, these findings suggest that in response to vaccination, VEGFR-3 signaling in LN LECs bias adaptive immune responses towards type 2 immunity. This highlights the role of lymphatics not just as passive conduits for fluid transport, but as having direct immunomodulatory function.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Kurtanich, T. R., Medellin, J. E. G., & Swartz, M. A. (2023). VEGFR-3 Stimulation on LECs Boosts Type 2 Immunity After Vaccination. The Journal of Immunology, 210(Supplement_1), 79.18. https://doi.org/10.4049/jimmunol.210.supp.79.18
MLA 9
Kurtanich, Trevin Robert, et al. “VEGFR-3 Stimulation on LECs Boosts Type 2 Immunity After Vaccination.” The Journal of Immunology, vol. 210, no. Supplement_1, 2023, p. 79.18. https://doi.org/10.4049/jimmunol.210.supp.79.18.
Chicago
Kurtanich, Trevin Robert, Jorge Emiliano Gomez Medellin, and Melody A. Swartz. 2023. “VEGFR-3 Stimulation on LECs Boosts Type 2 Immunity After Vaccination.” The Journal of Immunology 210 (Supplement_1): 79.18. https://doi.org/10.4049/jimmunol.210.supp.79.18.
Harvard
Kurtanich, T. R., Medellin, J. E. G. and Swartz, M. A. (2023) ‘VEGFR-3 Stimulation on LECs Boosts Type 2 Immunity After Vaccination’, The Journal of Immunology, 210(Supplement_1), p. 79.18. doi:10.4049/jimmunol.210.supp.79.18.
IEEE
T. R. Kurtanich, J. E. G. Medellin, and M. A. Swartz, “VEGFR-3 Stimulation on LECs Boosts Type 2 Immunity After Vaccination,” The Journal of Immunology, vol. 210, no. Supplement_1, p. 79.18, 2023, doi: 10.4049/jimmunol.210.supp.79.18.
BibTeX
@article{kurtanich2023vegfr,
title = {{VEGFR-3 Stimulation on LECs Boosts Type 2 Immunity After Vaccination}},
author = {Kurtanich, Trevin Robert and Medellin, Jorge Emiliano Gomez and Swartz, Melody A.},
journal = {The Journal of Immunology},
year = {2023},
volume = {210},
number = {Supplement_1},
pages = {79.18},
doi = {10.4049/jimmunol.210.supp.79.18},
url = {https://doi.org/10.4049/jimmunol.210.supp.79.18}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- VEGFR-3
- lymphatic endothelial cells
- VEGF-C
- Th2 immune response
- vaccination
- germinal center B cells
- IgG1
- IL-4
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Kurtanich, T. R., Medellin, J. E. G., & Swartz, M. A. (2023). VEGFR-3 Stimulation on LECs Boosts Type 2 Immunity After Vaccination. The Journal of Immunology, 210(Supplement_1), 79.18. https://doi.org/10.4049/jimmunol.210.supp.79.18
How many times has this paper been cited?
0 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at The Journal of Immunology: sign in and open the PDF from this page.
Who wrote this paper?
Trevin Robert Kurtanich, Jorge Emiliano Gomez Medellin, Melody A. Swartz.
What is the DOI of this paper?
10.4049/jimmunol.210.supp.79.18, permanently at https://doi.org/10.4049/jimmunol.210.supp.79.18. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.